Shanghai Yingmaide Medical Technology

Shanghai Yingmaide Medical Technology is a China-based healthcare and biomedical technology company headquartered in Shanghai. Publicly available business registry information indicates the company conducts medical research and experimental development and provides biomedical engineering technology services. External pipeline databases associate the company with at least one oncology-related clinical program, with cytokine-based drug activity linked to Interleukin-2, and patent activity related to an ACE2-Fc fusion protein. The company appears to operate as a small, active private subsidiary within the Yafei Bio group rather than as a standalone public biotech issuer.